Faculty, Staff and Student Publications
Publication Date
12-1-2025
Journal
Nature Aging
DOI
10.1038/s43587-025-01006-w
PMID
41266628
PMCID
PMC12705447
PubMedCentral® Posted Date
11-20-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Cerebral small vessel disease (cSVD) is a leading cause of stroke and dementia with no specific treatment, of which molecular mechanisms remain poorly understood. To identify potential biomarkers and therapeutic targets, we applied Mendelian randomization to examine over 2,500 proteins measured in plasma and, uniquely, cerebrospinal fluid, in relation to magnetic resonance imaging (MRI) markers of cSVD in more than 40,000 individuals. Here we show that 49 proteins are associated with MRI markers of cSVD, most prominently in cerebrospinal fluid. We highlight associations that are consistent across platforms and ancestries, and supported by complementary observational analyses, and we explore differences between fluids. The proteins are enriched in pathways related to the extracellular matrix, immune response and microglial activity. Many also associate with stroke and dementia, and several correspond to existing drug targets. Together, these findings reveal a robust biological fingerprint of cSVD and highlight opportunities for biomarker and drug discovery and repositioning.
Keywords
Cerebral Small Vessel Diseases, Humans, Biomarkers, Magnetic Resonance Imaging, Proteogenomics, Mendelian Randomization Analysis, Male, Female, Aged, Cerebrovascular disorders, Neurovascular disorders
Published Open-Access
yes
Recommended Citation
Caro, Ilana; Western, Daniel; Namba, Shinichi; et al., "Proteogenomics in Cerebrospinal Fluid and Plasma Reveals New Biological Fingerprint of Cerebral Small Vessel Disease" (2025). Faculty, Staff and Student Publications. 1225.
https://digitalcommons.library.tmc.edu/uthsph_docs/1225